Drugs, Devices, and Diagnostics
Latest | Media coverage | Commentary | Academic Literature | Legislation | Reports and Government Documents
Covering prescription medicines and medical devices, which includes instruments, implants, scans and tests, as well as screening and health promoting interventions.
Latest
Media coverage
Natural Health manufacturers frustrated at lack of progress on regulation
The body representing New Zealand natural product manufacturers says the lack of modern regulation for the sector means New Zealand companies continue to struggle to compete on the world stage.
Prescription for change: New Medical Products Bill expected
The Government has recently announced its plan to modernise the regulation of medicines and medical devices by replacing the Medicines Act 1981 with a new Medical Products Bill (Bill). It has also decided that natural health products would be regulated under a standalone bill, yet to be developed.
Puberty blocker use in New Zealand far higher than similar countries – study
New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
Commentary
HE PĀNUI WHAKAHAU A TE MANA WHAKAHAERE KAIWHAKAWĀ D STONE MEMORANDUM-DIRECTIONS OF PRESIDING OFFICER JUDGE D STONE
This memorandum-direction addresses material relevant to the Health Services and Outcomes Kaupapa Inquiry (Wai 2575).
Healthy Families NZ – a decade of impact
Health New Zealand | Te Whatu Ora’s Healthy Families NZ is marking ten years of impact with the release of an impact report ‘Reshaping our systems for a healthier Aotearoa New Zealand’.
Ministry of Health Annual Report for the year ended 30 June 2024
The Annual Report for the year ended 30 June 2024 sets out who we are and what we do, how we manage our business, our financial statements and statement of service performance as specified in Vote Health – Main Estimates of Appropriation 2023/24 and (where updated) in Vote Health – Supplementary Estimates of Appropriation 2023/24.
Academic Literature
Use of puberty-blocking hormones for gender dysphoria in New Zealand: descriptive analysis and international comparisons
The high rate of prescribing for probable gender dysphoria in New Zealand, and the decline after 2021, require further investigation.
Equity in national healthcare economic evaluation guidelines: Essential or extraneous?
Equity is given less attention than efficiency in HEE guidelines. This indicates that HTA agencies while subscribing to an extra-welfarist approach have a narrow evaluative space – focusing on maximising health and not considering the opportunity cost of the equity constraint.
New Zealand expands cancer treatment with funding boost
New Zealand's coalition government has announced an expansion in funding for cancer treatments, enabling Pharmac (Wellington, New Zealand), the country's drug-buying agency, to introduce 26 new cancer treatments as a part of the 54 new medicines package.
Legislation and Parliament
Pae Ora (Healthy Futures) Act 2022
The purpose of this Act is to provide for the public funding and provision of services in order to—
(a) protect, promote, and improve the health of all New Zealanders; and
(b) achieve equity in health outcomes among New Zealand’s population groups, including by striving to eliminate health disparities, in particular for Māori; and
(c) build towards pae ora (healthy futures) for all New Zealanders.
Reports and Government Documents
First Plunket site begins delivering childhood immunisations
From today, Plunket in Whāngarei will be offering childhood immunisations – the first of up to 27 sites nationwide, Health Minister Simeon Brown says.
Hawke’s Bay patients to benefit from new and improved radiology and cancer treatment services
Enabling works have begun this week on an expanded radiology unit at Hawke’s Bay Fallen Soldiers’ Memorial Hospital which will double CT scanning capacity in Hawke’s Bay to ensure more locals can benefit from access to timely, quality healthcare, Health Minister Simeon Brown says.
Consultation to increase ADHD medicine access begins
The proposal suggests broadening the range of people who can initiate treatment of stimulant medicines which, over time, would lead to more doctors and nurse practitioners being able to diagnose and treat ADHD.
Key issues
HEALTH SERVICES AND SYSTEMS
EQUITY
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI